2nd Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act/S.2333 - Pandemic and All-Hazards Preparedness and Response Act Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act. S.1375/H.R. 830 HELP Copays Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas
ALANNA TEMME LD, Rep. Jon Porter

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1967 (118th), H.R. 3290 (118th), H.R. 4421 (118th), H.R. 4507 (118th), H.R. 3561 (118th), S. 1375 (118th), H.R. 830 (118th), S. 2333 (118th), S. 127 (118th), S. 1339 (118th)

Taxation/Internal Revenue Code TAX

Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2673 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.